Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Kelly, MD
University College London Hospitals
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Basingstoke and North Hampshire Nhs Foundation Trust
Basingstoke, England, United Kingdom
Recruiting - Queen Elizabeth Hospital at University Hospital of Birmingham Nhs Trust
Birmingham, England, United Kingdom
Recruiting - Leeds Cancer Centre at St. James'S University Hospital
Leeds, England, United Kingdom
Recruiting - University Hospitals of Leicester Nhs Trust
Leicester, England, United Kingdom
Recruiting - St. George'S Hospital
London, England, United Kingdom
Recruiting - University College of London Hospitals
London, England, United Kingdom
Recruiting - South Manchester University Hospital
Manchester, England, United Kingdom
Recruiting - James Cook University Hospital
Middlesbrough, England, United Kingdom
Recruiting - University Hospital of Wales
Cardiff, Wales, United Kingdom
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2009
- Primary completion
- 31 Oct 2013
- Completion
- —
- Last update posted
- 12 Aug 2013
- Registered enrollment
- 242
- Registry id
- NCT01094964
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.